Literature DB >> 15368519

Internalization of the dengue virus is cell cycle modulated in HepG2, but not Vero cells.

Waranyoo Phoolcharoen1, Duncan R Smith.   

Abstract

While many studies have investigated the relationship between cell type and dengue virus infection, no study to date has examined the effect of cell physiology on permissiveness to infection. Unsynchronized and artificially synchronized cell populations at different stages of the cell cycle of two cell types (Vero and HepG2) were examined for permissiveness to infection by two dengue virus serotypes (serotypes 2 and 3) by determining both the levels of virus produced as well as the percentage of cells infected. Vero cells showed no significant differences between either viral production or percentage of cells infected as compared to unsynchronized cells for any of the phases investigated, although production of virus (for both serotypes 2 and 3) was somewhat lower for cells infected during S phase. In contrast, HepG2 cells were significantly more permissive for both infection and virus production in the G(2) phase as compared to other phases examined and serotype differences in permissiveness to infection were noted with cells in the M phase of the cell cycle. These results suggest that the cell cycle may be a mediator of cell permissiveness in some cell types.

Entities:  

Mesh:

Year:  2004        PMID: 15368519     DOI: 10.1002/jmv.20195

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

Review 1.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 2.  Dengue and its effects on liver.

Authors:  Jayanta Samanta; Vishal Sharma
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

3.  S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells.

Authors:  Anna-Marija Helt; Eva Harris
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Antiviral actions of flavanoid-derived compounds on dengue virus type-2.

Authors:  Mudiana Muhamad; Lee Yean Kee; Noorsaadah Abd Rahman; Rohana Yusof
Journal:  Int J Biol Sci       Date:  2010-05-23       Impact factor: 6.580

5.  Models of dengue virus infection.

Authors:  Dennis A Bente; Rebeca Rico-Hesse
Journal:  Drug Discov Today Dis Models       Date:  2006

6.  PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage.

Authors:  B H Huang; J L Zhuo; C H W Leung; G D Lu; J J Liu; C T Yap; S C Hooi
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

7.  Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection.

Authors:  Chih-Yeu Fang; Siang-Jyun Chen; Huey-Nan Wu; Yueh-Hsin Ping; Ching-Yen Lin; David Shiuan; Chi-Long Chen; Ying-Ray Lee; Kao-Jean Huang
Journal:  Viruses       Date:  2015-09-10       Impact factor: 5.048

8.  High-throughput quantitative proteomic analysis of dengue virus type 2 infected A549 cells.

Authors:  Han-Chen Chiu; Holger Hannemann; Kate J Heesom; David A Matthews; Andrew D Davidson
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  Characterization of dengue virus entry into HepG2 cells.

Authors:  Lukkana Suksanpaisan; Tharinee Susantad; Duncan R Smith
Journal:  J Biomed Sci       Date:  2009-02-04       Impact factor: 8.410

10.  Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization.

Authors:  Mohd-Hafifi Jamal; Wei-Choong Ch'ng; Khatijah Yusoff; Norazizah Shafee
Journal:  Cancer Cell Int       Date:  2012-08-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.